GI effects are the primary concern, primarily nausea, vomiting, diarrhea, and constipation
Companies entering the peptide market will need to go beyond current compounding requirements by clearly communicating risks, providing prominent safety and side effect warnings, implementing robust patient screening protocols, and steering consumers away from misleading peptide information circulating on social media, online forums, and unverified sellers
Some clinicians overlap the medications briefly during the transition, continuing phentermine while semaglutide titrates up, then discontinuing phentermine once semaglutide reaches therapeutic levels
Cell Migration and Cytoskeletal Studies Scientific literature has examined BPC-157 in relation to cellular migration, cytoskeletal organization, and tissue biology
Research Grade Foundation